Skip to main content
. 2018 Mar 27;62(4):e02328-17. doi: 10.1128/AAC.02328-17

TABLE 1.

Summary statistics of demographic dataa

Trial No. of patients Median wt (kg) (range) Median ht (cm) (range) Median age (yr) (range) No. of male patients
I 77 75.3 (61–97.7) 176.7 (161–190) 42.5 (19–55) 71
II 50 76.5 (50.9–112.4) 174.5 (138–200) 41.5 (19–63) 42
III 139 73.5 (64–140) 164 (145–186) 61 (19–90) 21
a

Summary statistics of demographic data from healthy volunteers receiving oral (trial I) or intravenous (trial II) administrations and from patients receiving intravenous administrations (trial III) of finafloxacin. Medians and ranges (minimum to maximum) are presented.